1. Blackboxstocks raised $2.25 million through senior debentures for operations. 2. Initial debentures: $250,000 at 7% interest, maturing by March 15, 2025. 3. Additional debentures: $2 million linked to a potential merger. 4. CEO emphasizes merger plans to enhance stockholder value and operational capital. 5. Conversion of additional debentures into stock limited to 9.9% ownership.

1. 39% of EFX group showed fibrosis improvement, surpassing placebo results. 2. 29% in ITT analysis demonstrated significant fibrosis reversal without worsening MASH. 3. Reversal of cirrhosis was noted in a subgroup not on GLP-1 therapy. 4. EFX presents a potential treatment breakthrough for compensated cirrhosis due to MASH. 5. Over 3 million Americans could face MASH cirrhosis by 2030.

1. P180 acquires majority stake in VNCE, enhancing growth potential. 2. Brendan Hoffman returns as CEO, aiming to drive profitability and innovation. 3. VNCE reduces debt by $27 million through strategic loans pay-down. 4. P180's operational expertise will support VNCE's digital capabilities. 5. This acquisition marks P180's third strategic investment since 2024.

1. Creatd acquires Flewber, enhancing its position in regional air mobility. 2. Flewber's services start at $199, offering affordable on-demand air travel. 3. Acquisition projected to add $3–4 million in annual revenue by 2025. 4. Flewber plans to expand operations to Florida, Las Vegas, and Dubai. 5. The regional air mobility market is projected to grow to $115 billion by 2035.

1. FPH reported a strong Q4 net income of $121 million. 2. Total liquidity reached $555.9 million, supporting future growth. 3. 2025 net income projected to exceed $200 million, with 10% growth. 4. Significant residential land sales bolster revenue, especially in Valencia. 5. Gateway Commercial Venture assets were sold, ceasing commercial operations.

1. Evolus anticipates over 30% revenue growth for 2025, exceeding previous guidance. 2. FDA approval for Evolysse™ expected within 90 days, enhancing product portfolio. 3. Fourth quarter 2024 revenue hit $79 million, up 30% from the prior year. 4. Evolus expanded accounts purchasing Jeuveau® by approximately 830 in Q4 2024. 5. Consumer loyalty program grew over 40%, showing strong brand engagement.

1. NANO Nuclear acquires patents for portable, modular microreactor technologies. 2. Patents enhance protections for ZEUS, ODIN, KRONOS, and LOKI reactors. 3. New patents support clean energy solutions and variable operations. 4. Technologies aim for various applications in industrial and military sectors.

1. JD.com proposed to buy Dada at $2.0 per ADS. 2. The offer includes a 42% premium over recent prices. 3. A special committee will evaluate the acquisition. 4. No definitive agreement has been reached yet. 5. There are no assurances that the transaction will proceed.

1. Mobix Labs acquires SCP Manufacturing to enhance operational efficiency. 2. The acquisition boosts market dominance in aerospace and defense sectors. 3. SCP supplies critical components for U.S. military applications, increasing strategic value. 4. The deal is set to close in Q2 2025, impacting financial plans. 5. Financing will combine cash and equity, highlighting Mobix's growth strategy.

1. Aptean will acquire Logility at $14.30 per share, a significant premium. 2. Logility's solutions support over 500 clients across 80 countries. 3. The transaction aims to enhance shareholder value and drive growth. 4. Logility will focus on long-term strategies as a private entity. 5. The deal expected to close in Q2 2025, pending shareholder approval.